CYH
VENTE TOTALE: 40 000 titres (~118 400,00 $ US)
- Insiders
- JENNINGS WILLIAM NORRIS
- Total bought
- —
- Total sold
- $118,400
- Last activity
- 2026-08-25
- Last synced
-
2026-08-31 10:14:36
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-27
CYH presents a deeply distressed financial profile with negative equity, debt-to-EBITDA exceeding 5x, and a negative interest coverage ratio, leaving virtually no margin of safety.
The first sentence of the analysis written for CYH on 2026-08-27 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 8.7% | 41.7% | 40.7% | 40.2% | 41.1% | |
| Ebit Margin | 12.8% | 6.7% | 7.0% | 5.9% | 10.3% | |
| Ebitda Margin | 16.2% | 9.9% | 10.4% | 9.6% | 13.8% | |
| Operating Profit Margin | -79.4% | 4.3% | 7.7% | 6.7% | 11.3% | |
| Pretax Profit Margin | 5.8% | -2.2% | 1.7% | 2.9% | 4.0% | |
| Continuous Operations Profit Margin | 5.4% | -2.9% | 0.1% | 1.5% | 3.0% | |
| Net Profit Margin | 4.1% | -4.1% | -1.1% | 0.4% | 1.9% | |
| Bottom Line Profit Margin | 4.1% | -4.1% | -1.1% | 0.4% | 1.9% | |
| Current Ratio | 1.465 | 1.408 | 1.498 | 1.410 | 1.472 | |
| Quick Ratio | 1.319 | 1.267 | 1.345 | 1.248 | 1.321 | |
| Solvency Ratio | 0.067 | -0.007 | 0.019 | 0.032 | 0.041 | |
| Cash Ratio | 0.118 | 0.016 | 0.018 | 0.054 | 0.214 | |
| Price To Earnings Ratio | 0.821 | -0.767 | -3.069 | 12.000 | 7.313 | |
| Price To Earnings Growth Ratio | -0.004 | -0.003 | 0.008 | -0.150 | -0.124 | |
| Forward Price To Earnings Growth Ratio | -0.004 | -0.003 | 0.008 | -0.150 | -0.124 | |
| Price To Earnings Diluted Ratio | 0.828 | -0.767 | -3.069 | 12.343 | 7.562 | |
| Price To Earnings Diluted Growth Ratio | -0.004 | -0.003 | 0.008 | -0.154 | -0.126 | |
| Price To Book Ratio | -0.300 | -0.206 | -0.293 | -0.407 | -1.230 | |
| Price To Sales Ratio | 0.033 | 0.031 | 0.033 | 0.046 | 0.136 | |
| Price To Free Cash Flow Ratio | 2.010 | 3.292 | -1.588 | -4.839 | -2.812 | |
| Price To Operating Cash Flow Ratio | 0.770 | 0.823 | 1.943 | 1.855 | -12.879 | |
| Debt To Assets Ratio | 0.877 | 0.861 | 0.842 | 0.845 | 0.843 | |
| Debt To Equity Ratio | -8.307 | -6.323 | -8.746 | -9.062 | -9.345 | |
| Debt To Capital Ratio | 1.137 | 1.188 | 1.129 | 1.124 | 1.120 | |
| Long Term Debt To Capital Ratio | 1.150 | 1.205 | 1.141 | 1.136 | 1.133 | |
| Financial Leverage Ratio | -9.472 | -7.343 | -10.384 | -10.731 | -11.091 | |
| Working Capital Turnover Ratio | 12.598 | 12.497 | 12.732 | 12.144 | 8.803 | |
| Operating Cash Flow Ratio | 0.246 | 0.205 | 0.098 | 0.137 | -0.055 | |
| Operating Cash Flow Sales Ratio | 0.043 | 0.038 | 0.017 | 0.025 | -0.011 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.383 | 0.250 | -1.224 | -0.383 | 4.580 | |
| Debt Service Coverage Ratio | 1.980 | 1.172 | 1.130 | 0.972 | 1.485 | |
| Interest Coverage Ratio | -11.397 | 0.628 | 1.150 | 0.957 | 1.584 | |
| Short Term Operating Cash Flow Coverage Ratio | 4.310 | 3.556 | 1.448 | 1.775 | -0.736 | |
| Operating Cash Flow Coverage Ratio | 0.047 | 0.040 | 0.017 | 0.024 | -0.010 | |
| Capital Expenditure Coverage Ratio | 1.621 | 1.333 | 0.450 | 0.723 | -0.279 | |
| Dividend Paid And Capex Coverage Ratio | 1.621 | 1.333 | 0.450 | 0.723 | -0.279 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 5.811 | 9.976 | 9.687 | 10.982 | 8.188 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 8.7% | ▼-33.1% | ▼-25.8% |
| Ebit Margin | 12.8% | ▲6.1% | ▲4.2% |
| Ebitda Margin | 16.2% | ▲6.3% | ▲4.2% |
| Operating Profit Margin | -79.4% | ▼-83.7% | ▼-69.5% |
| Pretax Profit Margin | 5.8% | ▲8.0% | ▲3.4% |
| Continuous Operations Profit Margin | 5.4% | ▲8.3% | ▲4.0% |
| Net Profit Margin | 4.1% | ▲8.2% | ▲3.8% |
| Bottom Line Profit Margin | 4.1% | ▲8.2% | ▲3.8% |
| Current Ratio | 1.465 | ▲0.057 | ▲0.014 |
| Quick Ratio | 1.319 | ▲0.052 | ▲0.019 |
| Solvency Ratio | 0.067 | ▲0.074 | ▲0.036 |
| Cash Ratio | 0.118 | ▲0.102 | ▲0.034 |
| Price To Earnings Ratio | 0.821 | ▲1.588 | ▼-2.439 |
| Price To Earnings Growth Ratio | -0.004 | ▼-0.001 | ▲0.050 |
| Forward Price To Earnings Growth Ratio | -0.004 | ▼-0.001 | ▲0.050 |
| Price To Earnings Diluted Ratio | 0.828 | ▲1.594 | ▼-2.552 |
| Price To Earnings Diluted Growth Ratio | -0.004 | ▼-0.002 | ▲0.052 |
| Price To Book Ratio | -0.300 | ▼-0.093 | ▲0.187 |
| Price To Sales Ratio | 0.034 | ▲0.002 | ▼-0.022 |
| Price To Free Cash Flow Ratio | 2.010 | ▼-1.282 | ▲2.797 |
| Price To Operating Cash Flow Ratio | 0.770 | ▼-0.053 | ▲2.268 |
| Debt To Assets Ratio | 0.877 | ▲0.016 | ▲0.024 |
| Debt To Equity Ratio | -8.307 | ▼-1.984 | ▲0.050 |
| Debt To Capital Ratio | 1.137 | ▼-0.051 | ▼-0.003 |
| Long Term Debt To Capital Ratio | 1.149 | ▼-0.056 | ▼-0.003 |
| Financial Leverage Ratio | -9.472 | ▼-2.129 | ▲0.332 |
| Working Capital Turnover Ratio | 12.598 | ▲0.102 | ▲0.844 |
| Operating Cash Flow Ratio | 0.246 | ▲0.041 | ▲0.120 |
| Operating Cash Flow Sales Ratio | 0.043 | ▲0.005 | ▲0.021 |
| Free Cash Flow Operating Cash Flow Ratio | 0.383 | ▲0.133 | ▼-0.338 |
| Debt Service Coverage Ratio | 1.980 | ▲0.808 | ▲0.632 |
| Interest Coverage Ratio | -11.397 | ▼-12.025 | ▼-9.981 |
| Short Term Operating Cash Flow Coverage Ratio | 4.309 | ▲0.754 | ▲2.239 |
| Operating Cash Flow Coverage Ratio | 0.047 | ▲0.007 | ▲0.023 |
| Capital Expenditure Coverage Ratio | 1.621 | ▲0.288 | ▲0.851 |
| Dividend Paid And Capex Coverage Ratio | 1.621 | ▲0.288 | ▲0.851 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 5.811 | ▼-4.165 | ▼-3.118 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $418.1M | $395.0M | $408.1M | $556.5M | $1.69B | |
| Enterprise value | $11.74B | $12.46B | $12.54B | $12.83B | $14.00B | |
| EV / Sales | 0.94x | 0.99x | 1.00x | 1.05x | 1.13x | |
| EV / Op. cash flow | 21.62x | 25.96x | 59.73x | 42.76x | -106.89x | |
| EV / Free cash flow | 56.43x | 103.83x | -48.81x | -111.53x | -23.34x | |
| EV / EBITDA | 5.81x | 9.98x | 9.69x | 10.98x | 8.19x | |
| Net debt / EBITDA | 5.60x | 9.66x | 9.37x | 10.51x | 7.20x | |
| Current ratio | 1.47x | 1.41x | 1.50x | 1.41x | 1.47x | |
| Income quality | 0.80x | -0.93x | -1.58x | 6.52x | -0.57x | |
| Graham net-net | -$89 | -$101 | -$102 | -$105 | -$108 | |
| Tax burden | 70.3% | 182.3% | -64.3% | 13.2% | 46.1% | |
| Interest burden | 45.4% | -33.6% | 23.8% | 48.5% | 39.0% | |
| Working capital | $1.03B | $956.0M | $1.07B | $896.0M | $1.11B | |
| Invested capital | $9.61B | $10.32B | $11.10B | $11.39B | $11.82B | |
| Return on assets | 3.9% | -3.7% | -0.9% | 0.3% | 1.5% | |
| Operating ROA | -72.7% | 3.8% | 6.6% | 5.5% | 9.0% | |
| Return on tangible assets | 5.2% | -5.1% | -1.3% | 0.4% | 2.1% | |
| Return on equity | -36.5% | 27.0% | 9.6% | -3.4% | -16.8% | |
| Return on invested capital | -83.2% | 4.6% | 0.6% | 3.3% | 7.9% | |
| Return on capital employed | -90.2% | 4.6% | 7.8% | 6.6% | 10.9% | |
| Earnings yield | 121.7% | -130.6% | -32.6% | 8.3% | 13.6% | |
| Free cash flow yield | 49.8% | 30.4% | -63.0% | -20.7% | -35.6% | |
| Capex / Op. cash flow | 61.7% | 75.0% | 222.4% | 138.3% | -358.0% | |
| Capex / Depreciation | 78.6% | 74.1% | 92.5% | 77.7% | 86.9% | |
| Capex / Sales | 2.7% | 2.8% | 3.7% | 3.4% | 3.8% | |
| SG&A / Sales | 0.0% | 2.4% | 2.6% | 2.6% | 2.5% | |
| R&D / Sales | 0.0% | 0.0% | 0.6% | 0.7% | 0.9% | |
| Stock comp / Sales | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Intangibles / Total assets | 26.2% | 28.2% | 28.8% | 29.9% | 29.5% | |
| Days sales outstanding | 66d | 71d | 69d | 64d | 64d | |
| Days payables outstanding | 27d | 39d | 40d | 34d | 36d | |
| Operating cycle | 76d | 87d | 85d | 82d | 82d | |
| Cash conversion cycle | 49d | 48d | 45d | 47d | 46d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+5.8%EV / Sales ▼-4.7%EV / EBITDA ▼-41.8%EV / Op. cash flow ▼-4.341Earnings yield ▲+2.524
Profitability
Return on equity ▼-0.635Return on assets ▲+0.075Return on invested capital ▼-0.878Return on capital employed ▼-0.948Operating ROA ▼-0.766Income quality ▲+1.733Tax burden ▼-1.120
Efficiency
Days sales outstanding ▼-4.682Days payables outstanding ▼-11.908Operating cycle ▼-10.781Cash conversion cycle ▲+1.127Capex / Sales ▼-0.002R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.057Net debt / EBITDA ▼-4.056Working capital ▲+70000000.000Invested capital ▼-710000000.000Intangibles / Total assets ▼-0.020
Change over 5 years
Valuation
Market cap ▼-75.2%EV / Sales ▼-17.0%EV / EBITDA ▼-29.0%EV / Op. cash flow ▲+128.503Earnings yield ▲+1.081
Profitability
Return on equity ▼-0.197Return on assets ▲+0.023Return on invested capital ▼-0.912Return on capital employed ▼-1.011Operating ROA ▼-0.817Income quality ▲+1.373Tax burden ▲+0.242
Efficiency
Days sales outstanding ▲+1.795Days payables outstanding ▼-9.378Operating cycle ▼-5.687Cash conversion cycle ▲+3.691Capex / Sales ▼-0.011R&D / Sales ▼-0.009
Balance-sheet strength
Current ratio ▼-0.007Net debt / EBITDA ▼-1.598Working capital ▼-89000000.000Invested capital ▼-2219000000.000Intangibles / Total assets ▼-0.033
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-21 Community Health Systems (CYH) Up 7.2% Since Last Earnings Report: Can It Continue? Community Health Systems (CYH) reported earnings 30 days ago. What''s next for the stock?
- 2026-08-17 Community Health Trades at a Deep Discount to Peers: Hold or Fold? CYH trades at a deep discount to peers as acquisitions, cost control and debt reduction progress, but cash flow remains a concern.
- 2026-07-23 Community Health Systems, Inc. (CYH) Q2 2026 Earnings Call Transcript Community Health Systems, Inc. (CYH) Q2 2026 Earnings Call Transcript
- 2026-07-23 Community Health Systems Q2 Earnings Call Highlights Community Health Systems NYSE: CYH reported second-quarter 2026 results below its internal expectations and reduced its full-year outlook, citing higher uninsured volumes, weaker elective surgical demand among commercially insured patients and unfavorable payer and service mix trends.
- 2026-07-23 Community Health Q2 Loss Wider Than Expected, 2026 View Lowered CYH posts a wider-than-expected Q2 loss as revenues fall and the company cuts its 2026 revenue, EBITDA and earnings outlook.
- 2026-07-22 Community Health Systems (CYH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Community Health Systems (CYH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 2026-07-22 Community Health Systems (CYH) Reports Q2 Loss, Lags Revenue Estimates Community Health Systems (CYH) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.05 per share a year ago.
- 2026-07-22 Community Health Systems, Inc. Announces Second Quarter Ended June 30, 2026 Results FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) (the “Company”) today announced financial and operating results for the three and six months ended June 30, 2026. The following highlights the financial and operating results for the three months ended June 30, 2026. Net operating revenues totaled $2.825 billion. Net income attributable to Community Health Systems, Inc. stockholders was $70 million, or $0.51 per share (diluted), compared to $282 million, or $2.09 per s.
- 2026-07-20 Sell Alert: 3 REITs Facing Likely Dividend Cuts Most REIT dividends remain safe, but not all. High yields can hide serious balance sheet risks. Three REITs may cut dividends soon.
- 2026-07-16 Can Higher Occupancy Offset Lower Admissions in CYH''s Q2 Earnings? Community Health heads into Q2 earnings with mixed operating trends as stronger occupancy meets lower admissions and a smaller hospital portfolio.